17
Total investments
1
Early stage
6
Mid stage
9
Late stage
11y
Years active
Portfolio
17 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2025
We specialize in the design and production of unmanned aerial vehicles for the civilian, military and law enforcement market
The core of our team consists of experienced engineers with a broad skill set and expert knowledge of UAV systems
We also provide product development and custom engineering services not only limited to the UAV field
Investor
Dec 2025
The Human Biome was established as a Medical University of Warsaw spin-off due to the commercialization of our scientific research. Initially at the University, then at the Human Biome, in close cooperation with academia, since 2014, we conduct research on the gut microbiome as a new type of biotherapeutic agent. Having very rich baggage of experience in hematology, transplantation, immunology, and microbiology, we have combined many fields of medicine and technology to enter the world of the microbiome and discover what is undiscovered.
HBI combines highly innovative microbiome knowledge and breakthrough technologies in one unique approach that is able to generate a pipeline of donor-independent New Generation Biotherapeutics (NGBs) as a Live Biotherapeutics Products (LBPs).
Technologies and microbiome products developed by HBI:
1. “MicroDrug®” - AI/ML-based in-silico and ultra-deep tech in-vitro lab composing Drug Discovery Platform to predict microbiota-based drugs:
- "Trapp MIcroBS" - in-silico computational platform predicting drug compositions
- “Q Lab” - highly innovative in-vitro laboratory applying microfluidic, genomic, culturomic and robotic technologies to synthesize New Generation Biotherapeutics.
2. Microbiome Biobank - over 20 000 samples collected to date, from unique donors and patients (triads) treated by in-house produced highly rich and viable microbiota transplant preparations (Mbiotix)
3. Fecal Microbiota Transplantation (FMT) Facility with Clinical Platform (HBI leads 8 clinical experiments based on FMT to discover context-oriented drug compositions)
4. “Mbiotix” - highest-quality FMT preparation delivered to over 1400 patients.
Currently, in the HBI pipeline are developed 4 New-Generation Biotherapeutics (NGB):
- anti-CDI NGB (anti Clostridioides difficile NGB)
- flagship anti-ARB/AI NGB (anti-antibiotic resistant bacteria and anti-infective NGB)
- immunobooster NGB (GvHD and immunooncology)
- longevity/wellbeing NGB.
Investor
Dec 2025
We are a bioengineering company and conduct R&D projects in the area of implantology. We help people with lower-limb asymmetry and short stature.
Investor
Sep 2025
Our mission is to improve the lives of our patients by offering them access to effective and verified pharmaceutical treatments in the convenient dosage form.
Investor
Mar 2025
Welcome to DBR77 Platform - your innovation partner for the digital future. We are a leading technology company specializing in the development of digital twins, the optimization of marketplace solutions and the creation of digital development roadmaps. Our goal is to provide production and logistics companies with a sustainable competitive advantage through our digital solutions.
Investor
Oct 2024
Specjalizujemy się w badaniach genetycznych i medycynie spersonalizowanej.
Oferujemy Asystenta Zdrowia i Życia - kompletny system złożony z: badania DNA wszystkich 24.000 genów, Raportu Predyspozycji Genetycznych, telekonsultacji ze specjalistami oraz aplikacji prozdrowotnej.
Pomagamy kreować „Przyszłość Świadomie”.
Investor
Sep 2024
🚀 WE BELIEVE that even the smallest entrepreneur should be able to validate his product and select marketing tactics that are effective for himself. We want to equip entrepreneurs with the ultimate future proof tactics and remove obstacles to creating businesses that have the potential to change the world. Digital First AI transforms exclusive marketing services into accessible and understandable technology.
🚀 DF.AI will recommend you the best marketing tactics based on answers to a few questions about your business. You will get access to a library of tactics where, in addition to recommendations, you will be able to view the strategies of popular brands and experienced marketers.
🚀 Sign for early access!
The number of accounts for early users is limited.
YOU CAN BE a part of an amazing community, dont lose your opportunity!
Investor
Dec 2023
Wealthon to innowacyjny ekosystem dla firm. Wchodząc do naszego świata zyskujesz partnera, finansowanie i narzędzia dla biznesu.
Kompleksowo wspieramy przedsiębiorców, zarówno w rozwoju, jak i w rozwiązywaniu bieżących problemów finansowych poprzez oferowanie nowoczesnych form finansowania. Kluczowym produktem w ofercie jest Wealthon POSCASH, czyli pożyczka pod obrót na terminalu płatniczym. Dodatkowo, oferujemy także Pożyczkę Pomostową na spłatę zobowiązań względem ZUS/US oraz Pożyczkę Ratalną na dowolny cel.
Wealthon to także narzędzia dla biznesu. Na Google Play i AppStore dostępny jest Wealthon WALLET, czyli mobilny portfel dla przedsiębiorców. W aplikacji można zyskać dostęp do Wealthon CARD z błyskawicznym limitem kredytowym, do 20 000 zł. W ofercie już niedługo pojawi się także Wealthon POS, czyli system, który ułatwia obsługę klienta oraz sprzedaż.
W 2023 roku otrzymaliśmy nagrodę w kategorii #LendingTech roku za aplikację Wealthon WALLET, a w 2021 r. zostaliśmy docenieni za wykorzystanie sztucznej inteligencji oraz machine learningu w procesie oceny zdolności kredytowej.
Investor
Aug 2023
Depilacja.pl to sieć salonów depilacji laserowej i klinik medycyny estetycznej. Jesteśmy na rynku od 2016 roku i mamy 65 salonów w Polsce, w skład których wchodzą salony własne oraz salony partnerskie.
Zatrudniamy blisko 180 osób i codziennie dokładamy wszelkich starań by tworzyć nie tylko przyjazną i bezpieczną przestrzeń dla naszych Klientów w salonach ale również budować silną, odpowiedzialną i zaangażowaną organizację dla naszych Pracowników.
Jesteśmy nie tylko marką beauty ale również technologiczną. Jako pierwsi wprowadziliśmy na polski rynek medyczny laser diodowy – SPEC 3 Hybrid, posiadający 3 różne długości fal lasera. Dzięki temu rozwiązaniu laser działa na różne rodzaje włosa oraz różne fototypy skóry. Ma wbudowany system chłodzący i dodatkową głowicę chłodzącą, która niweluje odczucia bólowe i jednocześnie usprawnia pracę kosmetologa podczas zabiegu. Dodatkowo stworzyliśmy specjalistyczną serię balsamów, które pozwalają zadbać o pielęgnację skóry po zabiegu, redukując ryzyko występowania podrażnień oraz SPF50.
Zorientowanie na klienta i słuchanie jego potrzeb było początkiem do rozszerzenia oferty w salonach Depilacja.pl, dlatego od 2022 roku w wybranych salonach oferujemy zabiegi modelowania sylwetki – endermologię i elektrostymulację mięśni.
Nasi kosmetolodzy są regularnie szkoleni z technik wykonywania zabiegów, obsługi klienta w tym technik sprzedaży. To tworzy spójny standard obsługi a to przekłada się na opinie wysokiego zadowolenia i satysfakcji klientów.
Investor
Jun 2023
FindAir is a med-tech company that develops telemedicine tools for respiratory diseases.
Our main product is FindAir ONE - A smart inhaler device that during normal use of an inhaler will track all valuable patients data. Synchronized with the FindAir app and FindAir platform gives you a complete digitalization of asthma and COPD therapy.
The process of remote treating and monitoring lung disease has never been so simple!
Investor
Jul 2022
Talkie is a voice AI platform that empowers healthcare providers to effectively engage patients to achieve better health outcomes through automating appointment management, prescription refill requests and other patient-centric interactions.
Investor
Apr 2022
HiProMine S.A. specializes in insect based raw materials production for livestock and companion animals.
We offer high quality insect meal (dry form), insect pulp (fresh meat), and insect dried larvae, produced from Black Soldier Fly - Hermetia illucens.
Our meals are dried and processed in low temperature which improves digestibility and nutritive values for animals.
Our production is compliant with veterinary control standards, biosecurity, prevention of diseases, and GMP+/HACCP rules. All substrates used in insect rearing are vegetable based and GMO free.
Looking to alternative and sustainable protein and fat sources, HiProMine has developed a technology reducing negative impact in the circular economy model.
Investor
Mar 2022
We are a med-tech company that creates artificial intelligence algorithms to support doctors in diagnosing rare (hidden) diseases early based on patients medical records i.e. laboratory test results, radiology and other descriptive medical data.
Show all 17 investments ↓
Experience · 21 entries
All (21)
Investments (17)
2025
Investor
Dec 2025
We specialize in the design and production of unmanned aerial vehicles for the civilian, military and law enforcement market
The core of our team consists of experienced engineers with a broad skill set and expert knowledge of UAV systems
We also provide product development and custom engineering services not only limited to the UAV field
Investor
Dec 2025
The Human Biome was established as a Medical University of Warsaw spin-off due to the commercialization of our scientific research. Initially at the University, then at the Human Biome, in close cooperation with academia, since 2014, we conduct research on the gut microbiome as a new type of biotherapeutic agent. Having very rich baggage of experience in hematology, transplantation, immunology, and microbiology, we have combined many fields of medicine and technology to enter the world of the microbiome and discover what is undiscovered.
HBI combines highly innovative microbiome knowledge and breakthrough technologies in one unique approach that is able to generate a pipeline of donor-independent New Generation Biotherapeutics (NGBs) as a Live Biotherapeutics Products (LBPs).
Technologies and microbiome products developed by HBI:
1. “MicroDrug®” - AI/ML-based in-silico and ultra-deep tech in-vitro lab composing Drug Discovery Platform to predict microbiota-based drugs:
- "Trapp MIcroBS" - in-silico computational platform predicting drug compositions
- “Q Lab” - highly innovative in-vitro laboratory applying microfluidic, genomic, culturomic and robotic technologies to synthesize New Generation Biotherapeutics.
2. Microbiome Biobank - over 20 000 samples collected to date, from unique donors and patients (triads) treated by in-house produced highly rich and viable microbiota transplant preparations (Mbiotix)
3. Fecal Microbiota Transplantation (FMT) Facility with Clinical Platform (HBI leads 8 clinical experiments based on FMT to discover context-oriented drug compositions)
4. “Mbiotix” - highest-quality FMT preparation delivered to over 1400 patients.
Currently, in the HBI pipeline are developed 4 New-Generation Biotherapeutics (NGB):
- anti-CDI NGB (anti Clostridioides difficile NGB)
- flagship anti-ARB/AI NGB (anti-antibiotic resistant bacteria and anti-infective NGB)
- immunobooster NGB (GvHD and immunooncology)
- longevity/wellbeing NGB.
Investor
Dec 2025
We are a bioengineering company and conduct R&D projects in the area of implantology. We help people with lower-limb asymmetry and short stature.
Investor
Sep 2025
Our mission is to improve the lives of our patients by offering them access to effective and verified pharmaceutical treatments in the convenient dosage form.
Investor
Mar 2025
Welcome to DBR77 Platform - your innovation partner for the digital future. We are a leading technology company specializing in the development of digital twins, the optimization of marketplace solutions and the creation of digital development roadmaps. Our goal is to provide production and logistics companies with a sustainable competitive advantage through our digital solutions.
Show all 21 entries ↓
Investment activity
2015–2025 · 17 investments
Recent (last 2 years)Earlier
